Keywords: vical, phase, i/ii, trial, allovectin-7, results, clinical

Vical's Phase I/II Trial Of Allovectin-7

Article | 03 April 1995

Print This

Results of a Phase I/II clinical trial of Vical's cancer immunotherapy product candidate Allovectin-7 suggest that direct gene transfer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in